Trials / Unknown
UnknownNCT03522792
Neurotensin - an Important Regulator of Appetite in Humans?
The Effect of Neurotensin on Appetite, Food Intake, Blood Glucose Regulation, Hormone Secretion, and the Degradation of Neurotensin in Vivo
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Neurotensin (NT) is a gut peptide released postprandially from the small intestine. It is known to exert a range of enterogastrone effects and in animal models it reduces food intake when administered by parenteral routes. This study investigates whether the anorexic effects of NT suggested by animal studies can be translated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Neurotensin | Intravenous infusion of neurotensin |
| OTHER | Saline | Intravenous infusion of saline |
| OTHER | Ad libitum meal | Participants will be served a large meal serving. They will be instructed to eat until they do not feel hungry anymore. |
| OTHER | Liquid meal | A standardized mixed liquid meal will be ingested to stimulate endogenous peptide hormone release |
Timeline
- Start date
- 2018-01-05
- Primary completion
- 2019-05-01
- Completion
- 2019-12-01
- First posted
- 2018-05-11
- Last updated
- 2019-11-12
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03522792. Inclusion in this directory is not an endorsement.